[Results of therapeutic use of ledakrin in cancer-induced pleural effusion].
D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D009564:Nitracrine / Q000627:therapeutic use*; D010996:Pleural Effusion / Q000188:drug therapy* / Q000209:etiology; D012075:Remission, Spontaneous
D000166:Acridines; D009564:Nitracrine
Wyniki stosowania ledakrinu w leczeniu chorych z nowotworowymi wysiekami do jam opłucnych.